WealthStone’s Avanos Medical AVNS Stock Holding History

WealthStone’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15	Closed	-$654	–	97
2019 Q2	$654	Buy	+15	New	+$642	﹤0.01%	769

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WealthStone's AVNS Position: Q3 2019 in Review

WealthStone sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 15 shares — an estimated $654 sold.

WealthStone first reported a position in AVNS in Q2 2019 and held it in 1 quarter. The position peaked at $654 in Q2 2019. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

WealthStone reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
WealthStone sold 15 Avanos Medical shares in Q3 2019, an estimated $654.
WealthStone first reported a position in Avanos Medical in Q2 2019 and held it in 1 quarter.
WealthStone's Avanos Medical position peaked at $654 in Q2 2019.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.